- Home
- AVTX vs NIXX Comparison
AVTX vs NIXX Comparison
Compare AVTX & NIXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVTX
- NIXX
- Stock Information
- Founded
- AVTX 2011
- NIXX 2010
- Country
- AVTX United States
- NIXX United States
- Employees
- AVTX N/A
- NIXX N/A
- Industry
- AVTX Biotechnology: Pharmaceutical Preparations
- NIXX
- Sector
- AVTX Health Care
- NIXX
- Exchange
- AVTX Nasdaq
- NIXX NYSE
- Market Cap
- AVTX 57.4M
- NIXX 49.9M
- IPO Year
- AVTX 2015
- NIXX N/A
- Fundamental
- Price
- AVTX $4.89
- NIXX $2.23
- Analyst Decision
- AVTX Strong Buy
- NIXX
- Analyst Count
- AVTX 7
- NIXX 0
- Target Price
- AVTX $31.00
- NIXX N/A
- AVG Volume (30 Days)
- AVTX 82.2K
- NIXX 373.8K
- Earning Date
- AVTX 08-11-2025
- NIXX 08-13-2025
- Dividend Yield
- AVTX N/A
- NIXX N/A
- EPS Growth
- AVTX N/A
- NIXX N/A
- EPS
- AVTX N/A
- NIXX N/A
- Revenue
- AVTX $441,000.00
- NIXX $1,786,387.00
- Revenue This Year
- AVTX N/A
- NIXX N/A
- Revenue Next Year
- AVTX N/A
- NIXX N/A
- P/E Ratio
- AVTX N/A
- NIXX N/A
- Revenue Growth
- AVTX N/A
- NIXX 54.16
- 52 Week Low
- AVTX $3.39
- NIXX $1.35
- 52 Week High
- AVTX $16.00
- NIXX $8.50
- Technical
- Relative Strength Index (RSI)
- AVTX 54.89
- NIXX N/A
- Support Level
- AVTX $4.63
- NIXX N/A
- Resistance Level
- AVTX $5.02
- NIXX N/A
- Average True Range (ATR)
- AVTX 0.27
- NIXX 0.00
- MACD
- AVTX 0.00
- NIXX 0.00
- Stochastic Oscillator
- AVTX 72.73
- NIXX 0.00
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
About NIXX NIXXY INC
Nixxy Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology.Recently, the Company acquired the license from GoLogiq, Inc. (GoLogiq), to operate its fintech technology (the GOLQ Technology) and sell products derived thereof, including its Createapp, Paylogiq, Gologiq, and Radix AI technology and products.. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.